REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·Jul 28 at 05:06 AMGSK-0.73%03692-0.49%
Sito Bio: Plans to repurchase company shares for 15 million to 30 million yuan36Kr·Mar 9 at 03:08 AM300583+2.96%
Sito Bio: The listing application for the chemical raw material drug Methylprednisolone has been approvedZhitong·Nov 3, 2025 at 02:57 AM300583+2.96%
Sito Bio released its performance for the first three quarters, with a net loss attributable to the parent company of 69.2303 million yuanZhitong·Oct 28, 2025 at 03:42 AM300583+2.96%
Sito Bio: Subsidiary Srey Pharmaceuticals received the CEP certificate for Dexamethasone Sodium Phosphate raw materialsZhitong·Oct 9, 2025 at 06:45 AM300583+2.96%
Sito Bio released its performance for the first half of the year, turning from profit to a loss of 52.6871 million yuanZhitong·Aug 25, 2025 at 06:47 AM300583+2.96%
Decrypting the stocks with major capital outflow: 587 stocks with a net outflow for 5 consecutive daysZhitong·Jul 18, 2025 at 08:03 AM601010+1.36%300583+2.96%
Sito Bio: The chemical raw material drug Budesonide has passed the GMP compliance inspectionZhitong·Jun 30, 2025 at 07:51 AM300583+2.96%
Sito Bio's subsidiary has obtained the CEP certificate for Mometasone Furoate APIZhitong·Jun 30, 2025 at 07:49 AM300583+2.96%
Sito Bio: Dexamethasone raw material has obtained the European CEP certificateZhitong·Jun 18, 2025 at 03:29 AM300583+2.96%
Sito Bio's subsidiary chemical raw material drug maleate indacaterol has received the approval notice for its listing applicationZhitong·Mar 7, 2025 at 01:58 AM300583+2.96%
Sito Bio expects a pre-loss, with an estimated annual net loss of 70 million to 100 million yuanZhitong·Jan 21, 2025 at 03:06 AM300583+2.96%
Pharmaceutical stocks rise against the trend, Hehua Co., Ltd. hits the daily limit36Kr·Jan 1, 2025 at 07:56 PM000813+0.92%300583+2.96%
